Astonea Labs Board Meeting Date
Astonea Labs intimated that its Board is scheduled on 14 Nov 2026 to consider unaudited half-year results. The trading window remains closed until 48 hours post-announcement.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
7 announcements with these filters
Astonea Labs intimated that its Board is scheduled on 14 Nov 2026 to consider unaudited half-year results. The trading window remains closed until 48 hours post-announcement.
Astonea Labs has incorporated a new subsidiary, 'Longevity Science Private Limited.' The company will invest Rs. 0.05 Crore to hold 51% equity share capital.
Astonea Labs Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b) of the SEBI LODR Regulations, 2015, for the quarter ended September 30, 2026.
Astonea Labs Ltd reported revenue from operations of ₹50.2 Cr and net profit of ₹3.2 Cr for H2 FY25.
Astonea Labs has resubmitted its standalone financial results for FY25 in PDF format following a BSE query regarding discrepancies in its initial XBRL-only submission.
Promoter Ashish Gulati acquired 14,000 shares of Astonea Labs Ltd from the open market between September 15 and 16, 2026.
Promoter Ashish Gulati acquired 14,000 equity shares of Astonea Labs Ltd via open market transactions between September 15 and 16, 2026.